Equasens (FRA:PHF) Total Operating Expense: €188.7 Mil (TTM As of Dec. 2025)


FRA:PHF Equasens FRA:PHF
93 GF Score
Price €52.77
GF Value €85.88
! 3 Warning Signs
View Full Analysis

What is Equasens Total Operating Expense?

Equasens FRA:PHF 93 Total Operating Expense is €188.7 Mil as of Dec. 2025. GuruFocus rates FRA:PHF with a GF Score™ of 93/100 and a GF Value™ of €85.88. The stock has 3 warning signs investors should review.

Equasens's Total Operating Expense for the six months ended in Dec. 2025 was €93.8 Mil. Equasens's Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 was €188.7 Mil.

Equasens Total Operating Expense Related Terms

Equasens Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Equasens's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Equasens Total Operating Expense Chart

Equasens Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 83.55 89.35 94.88 103.75 114.72

Equasens Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 46.16 108.00 108.75 94.90 93.76
FRA:PHF
93GF Score
Equasens FRA:PHF
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Equasens Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €188.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of €188.7 Mil mean?
Equasens (FRA:PHF) has a Total Operating Expense of €188.7 Mil as of Dec. 2025. Total operating expense is the primary recurring expense associated with central operations. View historical data on Equasens and its competitors.
Is Equasens' Total Operating Expense too high?
Equasens' current Total Operating Expense is €188.7 Mil. Overall, Equasens has a GF Score™ of 93/100, reflecting its overall financial health beyond just this single metric.
How does Equasens' Total Operating Expense compare to VEEV and BTSG?
Equasens' Total Operating Expense of €188.7 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Healthcare Providers & Services company?
A good Total Operating Expense depends on the Healthcare Providers & Services industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Equasens and its competitors. Equasens's current Total Operating Expense is €188.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Equasens stock overvalued right now?
Equasens (FRA:PHF) has a current Total Operating Expense of €188.7 Mil. The stock's GF Value™ is €85.88, compared to a current price of €52.77 — trading 38.6% below its estimated fair value. The current Total Operating Expense is €188.7 Mil. Equasens' overall GF Score™ is 93/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Equasens (FRA:PHF), the current Total Operating Expense is €188.7 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Equasens (FRA:PHF) Overvalued in 2026?

Based on GuruFocus' analysis, Equasens stock appears to be undervalued. The current stock price of €52.77 is trading 38.6% below its estimated GF Value™ of €85.88.

Key valuation signals for FRA:PHF:

  • Total Operating Expense: €188.7 Mil
  • GF Value™: €85.88 vs. price of €52.77 (38.6% below fair value)
  • GF Score™: 93/100 with 3 warning signs

No single metric tells the full story. See the FRA:PHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Equasens Business Description

Address 5 Allee de Saint-Cloud, Technopole de Nancy Brabois, Villers-les-Nancy, FRA, 54600
Equasens is engaged in the European healthcare sector, providing software solutions to all healthcare professionals (pharmacists, primary care practitioners, hospitals, Hospital-at-Home structures, retirement homes, health centers) and patients in both primary and secondary care sectors. The various activities that the company is involved in include: pharmacy software publishing and integration, publishing of IT solutions for health and medical/social establishments, and development of solutions and infrastructures for e-Health. With operations in France (its key revenue-generating market), Italy, Belgium, Germany, Ireland, and the United Kingdom, it is developing the healthcare platform and an ecosystem in France and Europe, benefiting people by making its technology services available.
93GF Score

Get the complete analysis for FRA:PHF

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€52.77
Price
€85.88
GF Value